Quantbot Technologies LP Increases Stock Position in MetLife, Inc. $MET

Quantbot Technologies LP lifted its stake in MetLife, Inc. (NYSE:MET) by 197.5% in the second quarter, Holdings Channel.com reports. The fund owned 37,341 shares of the financial services provider’s stock after purchasing an additional 24,789 shares during the period. Quantbot Technologies LP’s holdings in MetLife were worth $3,003,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Quaker Wealth Management LLC lifted its stake in MetLife by 198.2% in the 2nd quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 672 shares in the last quarter. MTM Investment Management LLC purchased a new position in shares of MetLife during the 2nd quarter valued at $37,000. GFG Capital LLC bought a new position in shares of MetLife in the second quarter worth $38,000. Abound Wealth Management raised its position in shares of MetLife by 652.3% in the second quarter. Abound Wealth Management now owns 489 shares of the financial services provider’s stock worth $39,000 after buying an additional 424 shares in the last quarter. Finally, Legend Financial Advisors Inc. bought a new stake in MetLife during the second quarter valued at $40,000. 94.99% of the stock is currently owned by institutional investors.

MetLife Stock Up 0.6%

Shares of NYSE:MET opened at $77.97 on Friday. The stock has a market capitalization of $51.38 billion, a P/E ratio of 14.68, a price-to-earnings-growth ratio of 0.75 and a beta of 0.76. The stock’s 50-day moving average price is $78.73 and its 200-day moving average price is $78.71. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $88.09.

MetLife (NYSE:MET) last released its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, beating analysts’ consensus estimates of $2.30 by $0.07. The company had revenue of $12.46 billion during the quarter, compared to analyst estimates of $18.64 billion. MetLife had a return on equity of 21.00% and a net margin of 5.30%.MetLife’s revenue for the quarter was down 5.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.95 EPS. On average, equities analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be paid a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, November 4th. MetLife’s dividend payout ratio is 42.75%.

Analyst Ratings Changes

A number of equities analysts have weighed in on MET shares. Cowen restated a “buy” rating on shares of MetLife in a research note on Friday, August 22nd. Keefe, Bruyette & Woods cut their price objective on MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a report on Tuesday, November 11th. Piper Sandler cut shares of MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price objective on the stock. in a research report on Friday, September 19th. Wells Fargo & Company dropped their target price on shares of MetLife from $96.00 to $92.00 and set an “overweight” rating for the company in a research report on Friday, November 7th. Finally, Jefferies Financial Group increased their price target on shares of MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a report on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.60.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.